Loading…
Drinking Water Funding for the Future Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Drinking Water Funding for the Future Act of 2021 This bill reauthorizes through FY2026 several drinking water programs, such as programs concerning efforts to assess risks to community water systems, deploy innovative water technologies, enforce compliance with standards under the Safe Drinking Water Act, monitor unregulated drinking water contaminants, assist water systems through the drinking water state revolving fund, protect source waters, test water quality in small and disadvantaged communities, and reduce lead in drinking water.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · first_quarter · Pharmacy
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Referred to the Subcommittee on Environment and Climate Change.
Referred to the Subcommittee on Water Resources and Environment.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Pharmacy
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Pharmacy
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1339 - Pharmacy Benefit Manager Reform Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4507 - Transparency in Coverage Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4883 - Medicare Common Ownership Transparency Act H.R.5378 - Lower Costs More Transparency Act H.R.5385 - Medicare PBM Accountability Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
2023 · second_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits H.R.2666 -- Medicaid MVP for Patients Act S.652 / H.R.2630 -- Safe Step Act H.R.2679 -- Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.3799 - CHOICE Arrangement Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
Client expense: $3,402,542 · Firm income: Not reported
2023 · second_quarter · Pharmacy
Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
Client expense: $3,402,542 · Firm income: Not reported
2023 · second_quarter · Health Issues
Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2666 - Medicaid MVP for Patients Act S.652 / H.R.2630 - Safe Step Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act S.954 / H.R.1488 - Affordable Insulin Now Act H.R.1503 - Prescription Information Modernization Act H.R.1352 - Increasing Access to Biosimilars Act S.1374 - Patient Right to Shop Act H.R.3799 - CHOICE Arrangement Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.574 - Increasing Prescription Drug Competition Act S.775 - Increasing Transparency in Generic Drug Applications Act H.R.1790 - Biologics Competition Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1522 - A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration
2022 · fourth_quarter · Clean Air and Water (quality)
Bills: H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; H.R. 3282 - Drinking Water Funding for the Future Act of 2021; H.R. 1352 (Lawrence)/S. 916 (Sanders) - Water Affordability, Transparency, Equity, and Reliability Act of 2021
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Clean Air and Water (quality)
Bills: H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; H.R. 3282 - Drinking Water Funding for the Future Act of 2021; H.R. 1352 (Lawrence)/S. 916 (Sanders) - Water Affordability, Transparency, Equity, and Reliability Act of 2021
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Clean Air and Water (quality)
Bills: H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; S. 2454 - Water Reuse and Resiliency Act of 2021; H.R. 3282 - Drinking Water Funding for the Future Act of 2021; S. 914 (Duckworth) - Drinking Water and Wastewater Infrastructure Act of 2021; H.R. 1352 (Lawrence)/S. 916 (Sanders) - Water Affordability, Transparency, Equity, and Reliability Act of 2021
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Clean Air and Water (quality)
S. 914 (Duckworth) Drinking Water and Wastewater Infrastructure Act of 2021; S.29 (Klobuchar)/H.R.2008 (Craig) Local Water Protection Act; H.R.2467 (Dingell), PFAS Action Act; H.R. 1915 (DeFazio) the Water Quality Protection and Job Creation Act of 2021; H.R.1881 (Garamendi) Federal Water Pollution Control Permitting Terms; H.R. 3293 (Rochester) Low Income Water Customer Assistance Programs Act of 2021; H.R.1848 (Pallone) Leading Infrastructure for Tomorrows America Act or the LIFT America Act; H.R.3282 (McKinley) Drinking Water Funding for the Future Act of 2021; S.479 (Wicker) Lifting Our Communities through Advance Liquidity for Infrastructure Act or the LOCAL Infrastructure Act;and S.2454 (Padilla) Water Reuse and Resiliency Act of 2021; H.R.5438 (Cartwright) Water Advanced Technologies for Efficient Resource Use Act of 2021; H.R.6088 (Gallego)/S.3282 (Kelly) Water Infrastructure Modernization Act of 2021.
Client expense: $220,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Clean Air and Water (quality)
Bills: H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; S. 2454 - Water Reuse and Resiliency Act of 2021; H.R. 3282 - Drinking Water Funding for the Future Act of 2021
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Clean Air and Water (quality)
S. 914 (Duckworth), Drinking Water and Wastewater Infrastructure Act of 2021; S. 29 (Klobuchar)/H.R.2008 (Craig), Local Water Protection Act; H.R. 2467 (Dingell), the PFAS Action Act; H.R. 1915 (DeFazio), the Water Quality Protection and Job Creation Act of 2021; H.R. 1881 (Garamendi) ,Federal Water Pollution Control Permitting Terms; H.R. 3293 (Rochester), Low Income Water Customer Assistance Programs Act of 2021; H.R. 1848 (Pallone), Leading Infrastructure for Tomorrows America Act or the LIFT America Act; H.R. 3282 (McKinley), Drinking Water Funding for the Future Act of 2021; S. 479 (Wicker), Lifting Our Communities through Advance Liquidity for Infrastructure Act or the LOCAL Infrastructure Act; and S.2454 (Padilla), Water Reuse and Resiliency Act of 2021.
Client expense: $260,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Clean Air and Water (quality)
S. 914 (Duckworth) Drinking Water and Wastewater Infrastructure Act of 2021, S. 29 (Klobuchar)/H.R.2008 (Craig) Local Water Protection Act, H.R. 2467, the PFAS Action Act, H.R. 1915 (DeFazio), Water Quality Protection and Job Creation Act of 2021, H.R. 1881 (Garamendi) Federal Water Pollution Control Permitting Terms, H.R. 3293 (Rochester) Low Income Water Customer Assistance Programs Act of 2021, H.R. 1848 (Pallone) Leading Infrastructure for Tomorrows America Act or the LIFT America Act, 1, H.R. 3282 (McKinley) Drinking Water Funding for the Future Act of 2021, and S. 479 (Wicker) Lifting Our Communities through Advance Liquidity for Infrastructure Act or the LOCAL Infrastructure Act, S.2454 (Padilla): Water Reuse and Resiliency Act of 2021
Client expense: $260,000 · Firm income: Not reported
Government targets: Bureau of Reclamation, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Clean Air and Water (quality)
Bills: H.R. 610 - San Francisco Bay Restoration Act; H.R. 1015 - Water Recycling Improvement and Investment Act; H.R. 4099 / S. 2334 - Large-Scale Water Recycling Project Investment Act; H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; S. 914 - Drinking Water and Wastewater Infrastructure Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; S. 2454 - Water Reuse and Resiliency Act of 2021; H.R. 3282 - Drinking Water Funding for the Future Act of 2021
Client expense: $130,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Reclamation, Environmental Protection Agency (EPA), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Oceanic & Atmospheric Administration (NOAA), Office of Management & Budget (OMB), SENATE, U.S. Fish & Wildlife Service (USFWS)
2021 · third_quarter · Clean Air and Water (quality)
Bills: H.R. 610 - San Francisco Bay Restoration Act; H.R. 1015 - Water Recycling Improvement and Investment Act; H.R. 4099 / S. 2334 - Large-Scale Water Recycling Project Investment Act; H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; S. 914 - Drinking Water and Wastewater Infrastructure Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; S. 2454 - Water Reuse and Resiliency Act of 2021; H.R. 3282 - Drinking Water Funding for the Future Act of 2021
Client expense: $120,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Reclamation, Environmental Protection Agency (EPA), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Oceanic & Atmospheric Administration (NOAA), Office of Management & Budget (OMB), SENATE, U.S. Fish & Wildlife Service (USFWS)
2021 · third_quarter · Clean Air and Water (quality)
S. 914 (Duckworth) Drinking Water and Wastewater Infrastructure Act of 2021, S. 29 (Klobuchar)/H.R.2008 (Craig) Local Water Protection Act, H.R. 1915 (DeFazio), Water Quality Protection and Job Creation Act of 2021, H.R. 1881 (Garamendi) Federal Water Pollution Control Permitting Terms, H.R. 3293 (Rochester) Low Income Water Customer Assistance Programs Act of 2021, H.R. 1848 (Pallone) Leading Infrastructure for Tomorrows America Act or the LIFT America Act, 1, H.R. 3282 (McKinley) Drinking Water Funding for the Future Act of 2021, and S. 479 (Wicker) Lifting Our Communities through Advance Liquidity for Infrastructure Act or the LOCAL Infrastructure Act, S.2454 (Padilla): Water Reuse and Resiliency Act of 2021
Client expense: $240,000 · Firm income: Not reported
Government targets: Bureau of Reclamation, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Clean Air and Water (quality)
S. 914 (Duckworth) Drinking Water and Wastewater Infrastructure Act of 2021, S. 29 (Klobuchar)/H.R.2008 (Craig) Local Water Protection Act, H.R. 1915 (DeFazio) Water Quality Protection and Job Creation Act of 2021, H.R. 1881 (Garamendi) Federal Water Pollution Control Permitting Terms, H.R. 3293 (Rochester) Low Income Water Customer Assistance Programs Act of 2021, H.R. 1848 (Pallone) Leading Infrastructure for Tomorrows America Act or the LIFT America Act, H.R. 1915 (DeFazio) Water Quality Protection and Job Creation Act of 2021, H.R. 3282 (McKinley) Drinking Water Funding for the Future Act of 2021, and S. 479 (Wicker) Lifting Our Communities through Advance Liquidity for Infrastructure Act or the LOCAL Infrastructure Act.
Client expense: $220,000 · Firm income: Not reported
Government targets: Bureau of Reclamation, HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Clean Air and Water (quality)
Draft Drinking Water Infrastructure Resilience and Sustainability Act H.R. 1512 the CLEAN Future Act - provisions related to SRF reauthorization, lead service line replacement, and PFAS remediation. H.R. 1848 the LIFT America Act - provisions related to SRF reauthorization, lead service line replacement, and PFAS remediation. S. 914 the Drinking Water and Wastewater Infrastructure Act H.R. 2467 the PFAS Action Act - provisions related to CERCLA and SDWA standards H.R. 3300 the Get the Lead Out Act H.R. 3267, the Protect Drinking Water from PFAS Act H.R. 3291, the Assistance, Quality, and Affordability Act H.R. 3282, the Drinking Water Infrastructure for the Future Act
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $3,402,542 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE